Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.075 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.073 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |